James Hippel, Chief Financial Officer at BIO-TECHNE Corp (TECH), sold 11,665 shares at $480.66 ($5.6M) on 2021-08-09, disclosed to the SEC on 2021-08-10.
Seasonal sale ($5.6M) by Chief Financial Officer — this insider has traded TECH in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $481.82 | 1,665 | $802K | 14.3% |
| 2 | $477.69 | 5,200 | $2.5M | 44.4% |
| 3 | $478.58 | 1,800 | $861K | 15.4% |
| 4 | $479.96 | 1,300 | $624K | 11.2% |
| 5 | $480.66 | 700 | $336K | 6.0% |
| 6 | $480.70 | 100 |
| $48K |
| 0.9% |
| 7 | $481.61 | 300 | $144K | 2.6% |
| 8 | $483.62 | 300 | $145K | 2.6% |
| 9 | $484.98 | 300 | $145K | 2.6% |
| Total | $479.31 avg | 11,665 | $5.6M | 100% |
| Filing → |
| TECH | SELL | 2021-09-07 | $10.1M | — | Filing → |
| TECH | SELL | 2021-07-14 | $8.0M | — | Filing → |
| TECH | SELL | 2021-06-09 | $6.8M | — | Filing → |